Channel 2
Educational session
Date
22.11.2020
Time
15:35 - 16:55
Location
Channel 2
Chairs
- Domenica Lorusso (Rome, Italy)
- Jae-Weon Kim (Seoul, Korea, Republic of)
The treatment of ovarian cancer in 2020 (ID 16)
Educational session
Role of surgery and intraperitoneal hyperthermic chemoperfusion (HIPEC) in ovarian cancer (ID 58)
Lecture Time
15:35 - 15:50
Speakers
- Jae-Weon Kim (Seoul, Korea, Republic of)
Session Name
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
22.11.2020
Time
15:35 - 16:55
The treatment of ovarian cancer in 2020 (ID 16)
Educational session
How PARP inhibitors change the first-line ovarian cancer treatment (ID 59)
Lecture Time
15:50 - 16:05
Speakers
- Isabelle L. Ray-Coquard (Lyon, CEDEX, France)
Session Name
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
22.11.2020
Time
15:35 - 16:55
The treatment of ovarian cancer in 2020 (ID 16)
Educational session
The role of homologous recombination deficiency (HRD) and its clinical implication: Do we need it? (ID 60)
Lecture Time
16:05 - 16:20
Speakers
- David SP Tan (Singapore, Singapore)
Session Name
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
22.11.2020
Time
15:35 - 16:55
The treatment of ovarian cancer in 2020 (ID 16)
Educational session
Perspectives in ovarian cancer treatment (immunotherapy focus) (ID 61)
Lecture Time
16:20 - 16:35
Speakers
- Domenica Lorusso (Rome, Italy)
Session Name
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
22.11.2020
Time
15:35 - 16:55
The treatment of ovarian cancer in 2020 (ID 16)
Educational session
LIVE Q&A (ID 62)
Lecture Time
16:35 - 16:50
Speakers
- Domenica Lorusso (Rome, Italy)
Session Name
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
22.11.2020
Time
15:35 - 16:55